Differential metabolism of the pyrrolizidine alkaloid, senecionine, in Fischer 344 and Sprague-Dawley rats

Archives of Pharmacal Research

Volumn 27, Issue 5, 2004, Pages 547-553

  Chung, Woon Gye ^a   Buhler, Donald R ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

CYP2C11; Flavin containing monooxygenase (FMO); Metabolism; Pyrrolizidine alkaloids (PAs); Species difference

Indexed keywords

PYRROLIZIDINE ALKALOID; SENECIONINE;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FISCHER 344 RAT; LIVER MICROSOME; MALE; METABOLISM; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; FEMALE; MALE; MICROSOMES, LIVER; PYRROLIZIDINE ALKALOIDS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 16544376826     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980130     Document Type: Article

References (45)

1. Anxiously, M., Pohjanvirta, R., Honkakoski, P., Torronen, R., and Tuomisto, J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain. Biochem. Pharmacol., 46, 651-659 (1993).
2. Arseculeratne, S. N., Gunatilaka, A. A., and Panabokke, R. G. Toxicity of some traditional medicinal herbs. J. Ethnopharmacol., 13, 323-335 (1985).
3. Augustine, J. A. and Zemaitis, M. A. A comparison of the effects of cyclosporine on the hepatic microsomal drug metabolism in three different strains of rat. Gen. Pharmacol., 20, 137-141 (1989).
4. Cashman, J. R. and Hanzlik, R. P. Microsomal oxidation of thiobenzamide: A photometric assay for the flavin-containing monooxygenase. Biochem. Biophys. Res. Commun., 98, 147-153 (1981).
5. Chesney, C. F. and Allen, J. R. Resistance of the guinea pig to pyrrolizidine alkaloid intoxication. Toxicol. Appl. Pharmacol., 26, 385-392 (1973).
6. Chou, M. W., Wang, Y. P., Yan, J., Yang, Y. C., Beger, R. D., Williams, L. D., Doerge, D. R., and Fu, P. P. Riddellineoxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelline. Toxicol. Lett., 145, 239-247 (2003).
7. Chung, W. G. and Buhler, D. R., The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs. Toxicol. Appl. Pharmacol., 127, 314-319 (1994).
8. Chung, W. G. and Buhler, D. R., Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine. Drug Metab. Dispos., 23, 1263-1267 (1995).
9. Chung, W. G., Miranda, C. L., and Buhler, D. R., A cytochrome P4502B form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea pig. Xenobiotica 25, 929-939 (1995).
10. Coulombe, R. A. Jr., Pyrrolizidine alkaloids in foods. Adv. Food Nutr. Res., 45, 61-99 (2003).
11. Debessae, W. T., Huan, J., and Cheeke, P. R., Interactions in sheep between tall fescue ergot alkaloids and hepatotoxic carbon tetrachloride and Senecio pyrrolizidine alkaloids. Vet. Hum. Toxicol., 41, 129-133 (1999).
12. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S., Purification and characterization of microsomal cytochrome P450s. Xenobiotica, 12, 701-716 (1982).
13. Guo, Z., Raeissi, S., White, R. B., and Stevens, J. C., Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab. Dispos., 25, 390-393 (1997).
14. Huan, J. Y., Miranda, C. L., Buhler, D. R., and Cheeke, P. R., Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids. Toxicol. Lett. 99, 127-137 (1998).
15. Kedzierski, B. and Buhler, D. R., Method for determination of pyrrolizidine alkaloids and their metabolites by high-performance liquid chromatography. Anal. Biochem., 152, 59-65 (1986).
16. Koster, A. S., Nieuwenhuis, L., and Frankhuijzen-Sierevogel, A. C., Comparison of microsomal drug-metabolizing enzymes in 14 rat inbred strains. Biochem. Pharmacol., 38, 759-765 (1989).
17. Kulkarni, S. G., Warbritton, A., Bucci, T. J., and Mehendale, H. M.m Antimitotic intervention with colchicine alters the outcome of o-DCB-induced hepatotoxicity in Fischer 344 rats. Toxicology, 27, 79-88 (1997).
18. Larsen-Su, S. and Williams, D. E., Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine. Drug Metab. Dispos., 24, 927-931 (1996).
19. Lawton, M. P. and Philpot, R. M., Molecular genetics of flavin-dependent monooxygenases. Pharmacogenetics, 3, 40-44 (1993a).
20. Lawton, M. P. and Philpot, R. M., Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains. J. Biol. Chem., 268, 5728-5734 (1993b).
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
22. Mattocks, A. R. and Bird, I., Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. Chem. Biol. Interact., 43, 209-222 (1983).
23. Mattocks, A. R., Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, New York (1986).
24. McLean, E. K., The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol. Rev. 22, 249-483 (1970).
25. Miranda, C. L., Chung, W. G., Reed, R. L., Zhao, X., Henderson, M. C., Wang, J. L., Williams, D. E., and Buhler, D. R., Flavin-containing monooxygenase: A major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. Biochem. Biophys. Res. Commun., 178, 546-552 (1991a).
26. Miranda, C. L., Reed, R. L., Guengerich, F. P., and Buhler, D. R., Role of cytochrome P450 IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis, 12, 515-519 (1991b).
27. Nagata, T., Williams, D. E., and Ziegler, D. M. Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenase: difference due to substrate size. Chem. Res. Toxicol., 3, 372-376 (1990).
28. Noller, B. N., Myers, S., Abegaz, B., Singh, M. M., Dronenberg, F., and Bodeker, G. Global forum on safety of herbal and traditional medicine: July 7, 2001, Gold Coast, Australia. J. Altern. Complement. Med., 7, 683-601 (2001).
29. Omura, R. and Sato, T., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2374 (1964).
30. Pan, L. C., Wilson, D. W., and Segall, H. J., Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease. Toxicology, 79, 21-35 (1993).
31. Rampersaud, A. and Walz, F. G., Polymorphisms of four hepatic cytochrome P450 in twenty-eight inbred strains of rat. Biochem. Gen., 25, 527-534 (1987).
32. Roeder, E., Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie, 55, 711-726 (2000).
33. Sato, R. and Omura, T., Cytochrome P450. Academic Press, New York, p233 (1978).
34. Simon, B., De Looze, S., Ronai, A., and Von Deimling, O., Identification of rat liver carboxylesterase isozymes (EC 3.1.1.1) using polyacrylamide gel electrophoresis and isoelectric focusing. Electrophoresis, 6, 575-582 (1985).
35. Steenkamp, V., Stewart, M. J., van der Merwe, S., Zuckerman, M., and Crowther, N. J., The effect of Senecio latifolius, a plant used as a South African traditional medicine, on a human hepatoma cell line. J. Ethnopharmacol., 78, 51-58 (2001).
36. Stegelmeier, B. L., Edgar, J. A., Colegate, S. M., Gardner, D. R., Schoch, T. K., Coulombe, R. A., and Molyneux, R. J. Pyrrolizidine alkaloid plants, metabolism and toxicity. J. Nat. Toxins, 8, 95-116 (1999).
37. Tsokos-Kuhn, J. O., Lethal injury by diquat redox cycling in an isolated hepatocyte model. Arch. Biochem. Biophys., 265, 415-424 (1988).
38. Waxman, D. J., Rat hepatic cytochrome P-450 isoenzyme 2c. J. Biol. Chem., 259, 15481-15490 (1984).
39. White, I. H. N. and Mattocks, A. R., Reaction of dihyropyrrolizines with deoxyribonucleic acids in vitro. Biochem. J., 129, 291-297 (1972).
40. White, I. N. H., Mattocks, A. R., and Butler, W. H., The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal species. Chem. Biol. Interact., 6, 207-218 (1973).
41. Williams, D. E., Reed, R. L., Kedzierski, B., Dannan, G. A., Guengerich, F. P., and Buhler, D. R., Bioactivation and detoxification of the pyrrolizidine alkaloid senecionine by cytochrome P450 enzymes in rat liver. Drug Metab. Dispos., 17, 387-392 (1989a).
42. Williams, D. E., Reed, R. L., Kedzierski, B., Ziegler, D. M., and Buhler, D. R., The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab. Dispos., 17, 380-386 (1989b).
43. Wood, A. W., Ryan, D. E., Thomas, P. E., and Levin, W., Regio-and stereo-selective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozymes. J. Biol. Chem., 258, 8839-8847 (1986).
44. Ziegler, D. M., Flavin-containing monooxygenase: catalytic mechanism and substrate specificities. Drug Metab. Rev., 19, 1-32 (1988).
45. Ziegler, D. M., Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol., 33, 179-199 (1993).